PRLD · Prelude Therapeutics Incorporated

Summary

Prelude Therapeutics Incorporated filed a Form 8-K on March 12, 2026, referencing a prior 8-K filing from March 15, 2023, under Item 8.01 Other Events and including exhibits consisting of an opinion and consent from Morgan, Lewis & Bockius LLP.

Key takeaways

• References prior 8-K filed March 15, 2023
• Exhibit 5.1: Opinion of Morgan, Lewis & Bockius LLP
• Exhibit 23.1: Consent of Morgan, Lewis & Bockius LLP